It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In recent years, several studies described the close relationship between the composition of gut microbiota and brain functions, highlighting the importance of gut-derived metabolites in mediating neuronal and glial cells cross-talk in physiological and pathological condition. Gut dysbiosis may affects cerebral tumors growth and progression, but the specific metabolites involved in this modulation have not been identified yet. Using a syngeneic mouse model of glioma, we have investigated the role of dysbiosis induced by the administration of non-absorbable antibiotics on mouse metabolome and on tumor microenvironment. We report that antibiotics treatment induced: (1) alteration of the gut and brain metabolome profiles; (2) modeling of tumor microenvironment toward a pro-angiogenic phenotype in which microglia and glioma cells are actively involved; (3) increased glioma stemness; (4) trans-differentiation of glioma cells into endothelial precursor cells, thus increasing vasculogenesis. We propose glycine as a metabolite that, in ABX-induced dysbiosis, shapes brain microenvironment and contributes to glioma growth and progression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Sapienza University, Department of Physiology and Pharmacology, Rome, Italy (GRID:grid.7841.a); Center for Life Nanoscience & Neuroscience Istituto Italiano di Tecnologia@Sapienza, Rome, Italy (GRID:grid.7841.a)
2 Sapienza University, Department of Physiology and Pharmacology, Rome, Italy (GRID:grid.7841.a)
3 Sapienza University, Department of Environmental Biology, Rome, Italy (GRID:grid.7841.a); Sapienza University, NMR-Based Metabolomics Laboratory (NMLab), Rome, Italy (GRID:grid.7841.a)
4 National Research Council (CNR), Institute of Molecular Biology and Pathology, Rome, Italy (GRID:grid.5326.2) (ISNI:0000 0001 1940 4177)
5 EMMA CNR, Monterotondo, Italy (GRID:grid.5326.2)
6 Sapienza University, Department of Physiology and Pharmacology, Rome, Italy (GRID:grid.7841.a); IRCCS Neuromed, Pozzilli, Italy (GRID:grid.419543.e) (ISNI:0000 0004 1760 3561)
7 IRCCS Neuromed, Pozzilli, Italy (GRID:grid.419543.e) (ISNI:0000 0004 1760 3561); Sapienza University, Laboratory Affiliated to Institute Pasteur Italia, Department of Physiology and Pharmacology, Rome, Italy (GRID:grid.7841.a)